International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 766-773 doi: 10.5281/zenodo.16890713
Original Article
The Risk Factors Associated with Adverse Outcome in Pediatric Convulsive Status Epilepticus in a Tertiary Care Hospital Kashmir India
 ,
 ,
Published
Aug. 17, 2025
Abstract

Objective: The study aimed to ascertain various risk factors associated with adverse outcomes of convulsive status epilepticus in children. Methods: Hospital based prospective observational study performed in department of Pediatrics in Children Hospital Government Medical College Srinagar Kashmir India from October 2020 to September 2022. Data were recorded with the help of a pre-formed proforma. Results: In this study 148 cases (85.1.0%) recovered, 26 (14.9%) died, and 10 (5.5%) left against medical advice. Among recovered, 10 cases (5.5%) developed new neurological sequelae. The various risk factors associated with significant mortality in this study were longer duration of status, acute symptomatic etiology, the requirement of early ventilatory support, impairment in hemodynamics, and alteration in metabolic environment of the patients. Our results were consistent with various other studies. Conclusion: Early termination of seizure activity at the earliest, and prudent management of associated co-morbidities like respiratory or circulatory impairment in these children would result in an improved outcome

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
1235 Views
182 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved